๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Osteoprogenitor Cells as Targets for Ex Vivo Gene Transfer

โœ Scribed by Dr. J. E. Onyia; D. W. Clapp; H. Long; J. M. Hock

Book ID
111486181
Publisher
American Society for Bone and Mineral Research
Year
1998
Tongue
English
Weight
436 KB
Volume
13
Category
Article
ISSN
0884-0431

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Secreted Gaussia luciferase as a sensiti
Secreted Gaussia luciferase as a sensitive reporter gene for in vivo and ex vivo studies of airway gene transfer
โœ Uta Griesenbach; Catarina C. Vicente; Megan J. Roberts; Cuixiang Meng; Samia Sou ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 967 KB

The cationic lipid GL67A is one of the more efficient non-viral gene transfer agents (GTAs) for the lungs, and is currently being evaluated in an extensive clinical trial programme for cystic fibrosis gene therapy. Despite conferring significant expression of vector-specific mRNA following transfect

Ex vivo gene transfer to mature skeletal
Ex vivo gene transfer to mature skeletal muscle by using adenovirus helper cells
โœ Shigemi Kimura; Makoto Ikezawa; Baohong Cao; Yasunari Kanda; Ryan Pruchnic; Jame ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 459 KB

## Background: Adenoviral gene transfer to adult skeletal muscle is hindered by several major limitations, including host immune responses and maturation-dependent loss of myofiber infectivity. ex vivo gene delivery is more efficient than direct viral injection in surmounting maturation-dependent a

Ex Vivo transduced liver progenitor cell
Ex Vivo transduced liver progenitor cells as a platform for gene therapy in mice
โœ Sihong Song; Rafal P. Witek; Yuanqing Lu; Young-Kook Choi; Donghang Zheng; Marda ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 825 KB

Allogeneic stem cell-based transplants may be limited by allograft rejection, as is seen with conventional organ transplantation. One way to avert such a response is to use autologous stem cells, but that may carry the risk of recurrence of the original disease, particularly in the context of a gene